01654cam a22003617a 450000100090000000300040000900500170001300800410003001000170007102000220008802000250011002000210013502000240015603500230018003500200020304000230022304200140024605000230026008200200028324502840030326000580058730000340064550400410067953301460072065000320086665000320089865000300093065000280096071001310098871000360111985600810115585600560123614727519OSt20220330175312.0070207s2007    dcua    sb    000 0 eng d  a  2007295550  a0309102804 (book)  a9780309102803 (book)  a0309663431 (pdf)  a9780309663434 (pdf)  a(OCoLC)ocm76815747  a(OCoLC)76815747  aHNKcpuldpulbeng  alccopycat00aRA643.8b.P75 200700a614.5/9939222200aPreventing HIV infection among injecting drug users in high-risk countries :ban assessment of the evidence /cCommittee on the Prevention of HIV Infection Among Injecting Drug Users in High-Risk Countries, Board on Global Health, Institute of Medicine of the National Academies.  aWashington, D.C. :bNational Academies Press,cc2007.  axvi, 282 p. :bill. ;c23 cm.  aIncludes bibliographical references.  aElectronic reproduction.bWashington, D.C. :cNational Academies Press,dc2006.nMode of access: World Wide Web.nMade available through NAP. 0aAIDS (Disease)xPrevention. 0aHIV infectionsxPrevention. 0aNeedle exchange programs. 0aIntravenous drug abuse.2 aInstitute of Medicine (U.S.).bCommittee on the Prevention of HIV Infection Among Injecting Drug Users in High-Risk Countries.2 aNational Academies Press (U.S.)413Table of contents onlyuhttp://www.loc.gov/catdir/toc/fy0711/2007295550.html40uhttp://www.nap.edu/books/0309102804/html/index.html